Four grantees of Catalytic Opportunity Fund announced

The Catalytic Opportunity Fund for Introduction and Scale-Up of New and Lesser-Used Postpartum Hemorrhage Medicines (NLUM-PPH COF) has awarded its first four grantees: 

• International Centre for Reproductive Health 
• Mama-Pikin Foundation (Phase 1 and 2)
• Rwenzori Centre for Research and Advocacy 
• Solina Centre for International Development and Research

The COF is managed by RHSC and the Clinton Health Access Initiative and funded by MSD for Mothers* and FCDO. Grantees will conduct preparatory activities that drive scale up of the use of heat-stable carbetocin (HSC) and tranexamic acid (TXA) by training master trainers on the use of both medicines and then rolling out facility-based trainings to health care workers, as well as providing mentorship and supportive supervision. These activities will be implemented in health facilities across seven counties in Kenya (International Centre for Reproductive Health), eight districts of Sierra Leone (Mama-Pikin Foundation), 10 districts of Tooro sub-region of Uganda (Rwenzori Centre for Research and Advocacy), and Cross River State in Nigeria (Solina Centre for International Development and Research). HSC is a life-saving medicine used for the prevention of postpartum hemorrhage (PPH), while TXA is used for the treatment of PPH. Both medicines have been included in WHO’s Recommendations for PPH and Model List of Essential Medicines.

*MSD for Mothers is an initiative of Merck & Co., Inc., Rahway, NJ, USA.

Category: Maternal Health Supplies Caucus